Aris Tsalouchos

Dr. Aris Tsalouchos

Division of Nephrology, Santa Maria Annunziata Hospital, Florence, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in World Journal of Transplantation
Verified
Journal Article
Open access
Maurizio SalvadoriMaurizio Salvadori
Maurizio Salvadori
Aris TsalouchosAris Tsalouchos
Aris Tsalouchos
Genomics, proteomics and molecular biology lead to tremendous advances in all fields of medical sciences. Among these the finding of biomarkers as non invasive indicators of biologic processes represents a useful tool in the field of transplantation. In addition to define the principal characteristics of the biomarkers, this review will examine the biomarker usefulness in the different clinical phases following renal transplantation. Biomarkers of ischemia-reperfusion injury and of delayed graft function are extremely important for an early diagnosis of these complications and for optimizing the treatment. Biomarkers predicting or diagnosing acute rejection either cell-mediated or antibody-mediated allow a risk stratification of the recipient, a prompt diagnosis in an early phase when the histology is still unremarkable. The kidney solid organ response test detects renal transplant recipients at high risk for acute rejection with a very high sensitivity and is also able to make diagnosis of subclinical acute rejection. Other biomarkers are able to detect chronic allograft dysfunction in an early phase and to differentiate the true chronic rejection from other forms of chronic allograft nephropathies no immune related. Finally biomarkers recently discovered identify patients tolerant or almost tolerant. This fact allows to safely reduce or withdrawn the immunosuppressive therapy.

6 January 2018 in World Journal of Nephrology
Verified
Journal Article
Open access
Maurizio SalvadoriMaurizio Salvadori
Maurizio Salvadori
Aris TsalouchosAris Tsalouchos
Aris Tsalouchos
Immunoglobulin G4-related kidney diseases: An updated review

28 October 2019 in World Journal of Transplantation
Verified
Journal Article
Open access
Maurizio SalvadoriMaurizio Salvadori
Maurizio Salvadori
Aris TsalouchosAris Tsalouchos
Aris Tsalouchos
Therapeutic apheresis in kidney transplantation: An updated review

29 July 2020 in World Journal of Transplantation
Verified
Journal Article
Open access
Maurizio SalvadoriMaurizio Salvadori
Maurizio Salvadori
Aris TsalouchosAris Tsalouchos
Aris Tsalouchos
Current protocols and outcomes of ABO-incompatible kidney transplantation

1 January 2011 in Case Reports in Transplantation
Verified
Journal Article
Open access
PDF file
LMLuciano Moscarelli
Luciano Moscarelli
FAFilomena Annunziata
Filomena Annunziata
AMAnduela Mjeshtri
Anduela Mjeshtri
NPNunzia Paudice
Nunzia Paudice
Aris TsalouchosAris Tsalouchos
Aris Tsalouchos
EBElisabetta Bertoni
Elisabetta Bertoni
Warts are benign proliferations of the skin and mucosa caused by infection with human papillomavirus. They are commonly treated with destructive modalities such as cryotherapy with liquid nitrogen, local injection of bleomycin, electrocoagulation, topical application of glutaraldehyde, and local and systemic interferon-βtherapy. These treatment modalities often cause pain and sometimes scarring or pigmentation after treatment. We herein report a case with a right index finger wart, which was successfully treated with a topical activated vitamin D.

18 March 2021 in World Journal of Transplantation
Verified
Journal Article
Open access
Maurizio SalvadoriMaurizio Salvadori
Maurizio Salvadori
Aris TsalouchosAris Tsalouchos
Aris Tsalouchos
Microbiota, renal disease and renal transplantation